Click Here
Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Pharmaceutical Technology Europe E-Alert
Advanstar Communications
 
 
 
 
 
TOP SEARCHES: HPLC method development //Animal testing // Biopharmaceutical market
In this issue
EU DTC advertising
J&J's Remicade fight
AstraZeneca & Merck
PTE on Twitter
US drug safety
Atherosclerosis vaccine
DILI genetic link
RAPS in Europe
BioPartners & Biferonex
Key Topic Updates

 

Survey
How likely is it that international regulators will agree to an integrated drug approval process?
  Very likely
  Possibly
  Not likely
  Never!

This week we would like to know...

What is your preferred method of receiving professional information?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

June 05, 2009
EU DTC rules to change?
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is seeking opinions on a European Commission (EC) proposal that would allow drugmakers to disseminate certain information on prescription medicines directly to European patients. More...
J&J fights for Remicade rights
Johnson & Johnson (J&J) is making a break for escape with global sales of the rheumatoid arthritis treatment Remicade, which the company currently shares with Schering-Plough via a distribution agreement. More...
AstraZeneca & Merck in unique deal
In a novel collaboration, pharma giants AstraZeneca and Merck will investigate the potential benefits of combining their two early-stage compounds for the treatment of solid cancer tumours .More...
Tweet tweet!
Follow Pharmaceutical Technology Europe on Twitter! More...
US issues new drug safety guidelines
A discussion draft of the Food Safety Enhancement Act of 2009 has been released, which also contains measures relating to drug safety. More...
Atherosclerosis vaccine receives EU funding
Austria-based AFFiRiS AG is receiving financial support worth several hundred thousand euro for its atherosclerosis vaccine development programme from the European Union's EuroTransBio call. More...
Genetic link to drug-induced liver injury found
The International Serious Adverse Event Consortium (SAEC), a nonprofit partnership, has helped the FDA gain significant understanding of the genetic basis for drug-induced liver injury (DILI). More...
RAPS enters Europe
The Regulatory Affairs Professionals Society (RAPS) — the world's largest international membership organization of regulatory professionals in the medical device, pharmaceutical and biotechnology sectors — has opened a European office in Brussels (Belgium) that will support programmes, events and operations across Europe, as well as serve as the region's headquarters. More...
Marketing authorization withdrawn for Biferonex
BioPartners GmbH (Switzerland) has formally notified the European Medicines Agency (EMEA) of its decision to withdraw the application of a centralized marketing authorization for Biferonex (interferon beta 1a), 6 million-international-unit solution for injection, prefilled syringes for subcutaneous administration. More...
Product Profile
MeettheBoss
The Pharmaceutical Industry have been targeted by the online Financial Community MeettheBoss. MeettheBoss, originally focused on the financial services sector, has launched a new section dedicated to the Pharmaceutical Industry. The secure platform that MeettheBoss provided for the finance executives allowed them to communicate openly, free from vendors and the media. Over 40,000 members currently network on the site, all of them protected by the secure walls that surround the MeettheBoss site.
Read more...
Key Topic Updates
June events
Dosage forms articles
Packaging & labeling articles

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.